Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
the Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
1 other identifier
interventional
114
0 countries
N/A
Brief Summary
Placenta previa and accreta both could potentially cause serious postpartum hemorrhage and even maternal death. Interventional radiological techniques have been developed to limit massive hemorrhage during caesarean section. This study investigated the efficacy of prophylactic internal iliac artery balloon catheterization in management for placenta previa and accreta.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 17, 2016
CompletedNovember 17, 2016
November 1, 2016
1.3 years
November 15, 2016
November 16, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
blood loss
intraoperative
Secondary Outcomes (3)
operation duration
intraoperative
fluid transfusion
intraoperative
blood transfusion
intraoperative
Study Arms (2)
Balloon group
EXPERIMENTALProphylactic Internal Iliac Artery Balloon Catheterization
Control group
NO INTERVENTIONno intervention
Interventions
Between June 2015 and August 2016
Eligibility Criteria
You may qualify if:
- Pregnant women were eligible if they were diagnosed to have placenta previa and accreta by sonographic examination or Magnetic Resonance Imaging.
You may not qualify if:
- Any case who had bleeding disorder or underwent emergency cesarean delivery was excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Deng Dongruilead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor, chief doctor
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 17, 2016
Study Start
June 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
November 17, 2016
Record last verified: 2016-11